Medicine and Dentistry
Prevalence
95%
Parkinson's Disease
74%
Disease
72%
Clinical Trial
67%
Infection
63%
Diabetes
61%
Physical Activity
51%
COVID-19
48%
Medicine
47%
Arm
44%
Systematic Review
43%
Medical Examination
42%
Public Health
41%
Cohort Analysis
41%
Randomized Controlled Trial
40%
Meta-Analysis
38%
Chagas Disease
36%
Pooled Analysis
34%
Biological Marker
34%
Arteriosclerosis
34%
Drug Megadose
32%
Malignant Neoplasm
30%
Cardiovascular Risk
30%
Ivermectin
29%
Personalized Medicine
29%
Observational Study
29%
Oncology
29%
Cardiovascular System
28%
Radiation Therapy
28%
Body Mass Index
27%
Adverse Event
26%
Diagnosis
26%
Cohort Effect
25%
Diet Quality
25%
Benzodiazepine
25%
Red Wine
25%
Lifestyle Modification
25%
Cross Sectional Study
24%
Placebo
24%
Odds Ratio
23%
microRNA
23%
Population
23%
Single Drug Dose
22%
Schistosomiasis
22%
Progression Free Survival
22%
Clinical Trial Design
21%
Onchocerciasis
20%
Obesity
20%
Randomized Clinical Trial
20%
Health Care Cost
20%
Helminth
20%
Moxidectin
19%
Comorbidity
19%
Chemotherapy
18%
Impaired Glucose Tolerance
18%
Benznidazole
18%
Albendazole
18%
Health Outcomes
18%
Severe Acute Respiratory Syndrome Coronavirus 2
17%
Fexinidazole
17%
Onchocerca volvulus
17%
Frailty
17%
Drug Therapy
17%
Hemoglobin A1c
17%
Drug Screening
17%
Mild Cognitive Impairment
17%
Out of Hospital Cardiac Arrest
17%
Gut Microbiome
17%
Prostate Cancer
17%
Neglected Tropical Diseases
17%
Network Meta-Analysis
17%
Human Immunodeficiency Virus
17%
Adolescence
17%
Metabolic Syndrome
17%
Maturity Onset Diabetes of the Young
17%
Insulin Dependent Diabetes Mellitus
17%
Cardiovascular Disease
16%
Mediterranean Diet
15%
Breast Cancer
15%
Cognitive Defect
14%
Health Status
14%
Hazard Ratio
14%
Proportional Hazards Model
14%
Cardiometabolic Risk
13%
Digital Health
13%
Overall Survival
13%
Hypercholesterolemia
13%
Depression
13%
Dietary Intake
12%
Early Diagnosis
12%
Chronic Disease
12%
Degenerative Disease
12%
Melanoma
12%
Hypnotic
12%
Hypoglycemia
12%
Monotherapy
12%
Quality of Life
12%
Dietary Pattern
12%
Phase II Trials
12%
Progressive Supranuclear Palsy
11%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Prevalence
88%
Disease
77%
Parkinson's Disease
59%
Infection
57%
Adverse Event
56%
Randomized Controlled Trial
54%
Drug Development
44%
Artesunate
43%
Combination Therapy
41%
Biological Marker
41%
Placebo
38%
Schistosomiasis
37%
Malignant Neoplasm
36%
Chagas Disease
35%
Amodiaquine
34%
Multiple Chronic Conditions
34%
Out of Hospital Cardiac Arrest
34%
Pharmacokinetics
33%
Antimalarial Agent
33%
Monotherapy
31%
Observational Study
31%
Praziquantel
30%
Ivermectin
29%
Elimination
26%
Benzodiazepine
25%
Normal Human
22%
Artemisinin
22%
Obesity
21%
Hair Analysis
21%
Tablet
20%
Ethanol
20%
Cardiovascular Disease
20%
Cohort Study
20%
Chemotherapy
20%
HIV
19%
Progression Free Survival
18%
Benznidazole
18%
Albendazole
18%
Helminth
18%
Headache
17%
Base
17%
Lassa Fever
17%
Chronic Pain
17%
Levodopa-Induced Dyskinesia
17%
Carotid Atherosclerosis
17%
Arteriosclerosis
17%
Sustained Release
17%
Flucytosine
17%
Bioavailability
17%
Hospital Mortality
17%
Cardiovascular Risk
17%
Fexinidazole
17%
Prostate Cancer
17%
Onchocerca volvulus
17%
Clinical Trial Design
17%
Microfilaria (Nematode Larva)
17%
Acute Heart Infarction
17%
microRNA
17%
Moxidectin
17%
Rare Disease
15%
Schistosoma
14%
Randomized Clinical Trial
14%
Overall Survival
14%
Drug Safety
14%
Hemoglobin A1c
14%
Combination Drug
13%
Malaria Falciparum
13%
Health Status
13%
Hypnotic
12%
Intestine Volvulus
12%
Phase II Trials
12%
Environmental Exposure
12%
Neuron Specific Enolase
11%
Syndrome
11%
Group Trial
11%
Exposure Assessment
11%
Multiple Myeloma
11%
Cross-Sectional Study
11%
microRNA 124
10%
African Trypanosomiasis
10%
Off-Label Use
10%
Anemia
10%
Tropical Disease
10%
Comorbidity
10%
Immunoglobulin E
10%
Nifurtimox
10%
Circulating microRNA
9%
Skin Leishmaniasis
9%
Loiasis
9%
Trypanosoma Brucei Gambiense
9%
Onchocerciasis
9%
SARS Coronavirus
9%
Drug Resistance
9%
Parasite Clearance
8%
Malaria
8%
Impulse Control Disorder
8%
Valerian
8%
Cancer Registry
8%
Injury
8%